Valeo Financial Advisors, LLC Iterum Therapeutics PLC Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$0.31 - $0.45 $6,386 - $9,270	-20,600 Closed	0 $0
Q4 2021 Jan 07, 2022	BUY	$0.39 - $0.74 $3,120 - $5,920	8,000 Added 63.49%	20,600 $8,000
Q3 2021 Nov 02, 2021	BUY	$0.54 - $2.29 $6,804 - $28,854	12,600 New	12,600 $7,000
Q2 2021 Jul 22, 2021	SELL	$0.97 - $2.39 $3,977 - $9,799	-4,100 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$0.97 - $2.73 $3,977 - $11,193	4,100 New	4,100 $6,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.